View in EDS PDF Full Text

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
Authors: Mørk SK; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kadivar M; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Bol KF; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Westergaard MCW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Skadborg SK; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Overgaard N; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Sørensen AB; Evaxion Biotech A/S, Denmark., Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Yde CW; Diagnostic Center Rigshospitalet, Genomic Medicine Rigshospitalet, Copenhagen, Denmark., Trolle T; Evaxion Biotech A/S, Denmark., Garde C; Evaxion Biotech A/S, Denmark., Friis-Nielsen J; Evaxion Biotech A/S, Denmark., Nørgaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Kringelum JV; Evaxion Biotech A/S, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Source: Oncoimmunology [Oncoimmunology] 2022 Jan 10; Vol. 11 (1), pp. 2023255. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35036074
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mørk+SK%22">Mørk SK</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kadivar+M%22">Kadivar M</searchLink>; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Bol+KF%22">Bol KF</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Draghi+A%22">Draghi A</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Skadborg+SK%22">Skadborg SK</searchLink>; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Overgaard+N%22">Overgaard N</searchLink>; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Sørensen+AB%22">Sørensen AB</searchLink>; Evaxion Biotech A/S, Denmark.<br /><searchLink fieldCode="AU" term="%22Rasmussen+IS%22">Rasmussen IS</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Andreasen+LV%22">Andreasen LV</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Yde+CW%22">Yde CW</searchLink>; Diagnostic Center Rigshospitalet, Genomic Medicine Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Trolle+T%22">Trolle T</searchLink>; Evaxion Biotech A/S, Denmark.<br /><searchLink fieldCode="AU" term="%22Garde+C%22">Garde C</searchLink>; Evaxion Biotech A/S, Denmark.<br /><searchLink fieldCode="AU" term="%22Friis-Nielsen+J%22">Friis-Nielsen J</searchLink>; Evaxion Biotech A/S, Denmark.<br /><searchLink fieldCode="AU" term="%22Nørgaard+N%22">Nørgaard N</searchLink>; Department of Urology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Christensen+D%22">Christensen D</searchLink>; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kringelum+JV%22">Kringelum JV</searchLink>; Evaxion Biotech A/S, Denmark.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Hadrup+SR%22">Hadrup SR</searchLink>; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Svane+IM%22">Svane IM</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2022 Jan 10; Vol. 11 (1), pp. 2023255. <i>Date of Electronic Publication: </i>2022 Jan 10 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35036074
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2021.2023255
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2023255
    Titles:
      – TitleFull: Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mørk SK
      – PersonEntity:
          Name:
            NameFull: Kadivar M
      – PersonEntity:
          Name:
            NameFull: Bol KF
      – PersonEntity:
          Name:
            NameFull: Draghi A
      – PersonEntity:
          Name:
            NameFull: Westergaard MCW
      – PersonEntity:
          Name:
            NameFull: Skadborg SK
      – PersonEntity:
          Name:
            NameFull: Overgaard N
      – PersonEntity:
          Name:
            NameFull: Sørensen AB
      – PersonEntity:
          Name:
            NameFull: Rasmussen IS
      – PersonEntity:
          Name:
            NameFull: Andreasen LV
      – PersonEntity:
          Name:
            NameFull: Yde CW
      – PersonEntity:
          Name:
            NameFull: Trolle T
      – PersonEntity:
          Name:
            NameFull: Garde C
      – PersonEntity:
          Name:
            NameFull: Friis-Nielsen J
      – PersonEntity:
          Name:
            NameFull: Nørgaard N
      – PersonEntity:
          Name:
            NameFull: Christensen D
      – PersonEntity:
          Name:
            NameFull: Kringelum JV
      – PersonEntity:
          Name:
            NameFull: Donia M
      – PersonEntity:
          Name:
            NameFull: Hadrup SR
      – PersonEntity:
          Name:
            NameFull: Svane IM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 01
              Text: 2022 Jan 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1